Glass House Brands (GLAS) Change in Working Capital (2022 - 2023)

Glass House Brands' (GLAS) quarterly Change in Working Capital came in at $22.3 million in Q2 2023, up 76.74% year-on-year from $12.6 million in Q2 2022, and down 23.89% on a QoQ basis from $29.2 million in Q1 2023.

Glass House Brands (GLAS) Change in Working Capital (2022 - 2023) Analysis & Trends

Glass House Brands (GLAS) has 2 years of Change in Working Capital data on file, last reported at $22.3 million in Q2 2023.

  • On a quarterly basis, Change in Working Capital rose 76.74% year-over-year to $22.3 million in Q2 2023; TTM through Jun 2023 was $76.0 million, a N/A change from a year earlier, with the FY2022 full-year figure at $11.9 million, changed N/A from the prior year.
  • Change in Working Capital for Q2 2023 stood at $22.3 million, down from $29.2 million in the prior quarter.
  • Over the last five years, Change in Working Capital for GLAS reached as high as $29.2 million in Q1 2023 and fell as low as $5.2 million in Q1 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Working Capital (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn -617.00 Mn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn -
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn -
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn -
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn -
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn -
10 Glass House Brands 873.84 Mn 845.91 Mn 10.02 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2023 22.26 Mn
Jun 30, 2023 22.26 Mn
Mar 31, 2023 29.25 Mn
Mar 31, 2023 29.25 Mn
Dec 31, 2022 11.89 Mn
Dec 31, 2022 11.89 Mn
Jun 30, 2022 12.60 Mn
Jun 30, 2022 12.60 Mn
Mar 31, 2022 5.20 Mn
Mar 31, 2022 5.20 Mn